|April 14, 2014|
|16:58 EDT||ATHN||athenahealth reinstated with a Market Perform at Raymond James|
Raymond James reinstated coverage of athenahealth with a Market Perform rating, down two notches from its previous rating of Strong Buy. The firm sees limited potential for positive earnings surprises.
News For ATHN From The Last 14 Days
|November 17, 2015|
|15:02 EDT||ATHN||athenahealth announced new services agreement with TeamPraxis|
athenahealth and TeamPraxis, a physician service organization in Hawaii, announced a new services agreement which enables TeamPraxis to access and use the athenaNet platform to implement and support the athenaOne suite of services and athenaCommunicator Enterprise population health service.
|11:23 EDT||ATHN||Barclays says sell athenahealth as new customers get harder to find|
Barclays downgraded athenahealth (ATHN) to Underweight, the firm's equivalent of a Sell rating, in a note to investors today. The company's prospects in the ambulatory care market look weak and its growth rate appears to be unsustainable, the firm contended. athenahealth provides cloud-based services and mobile applications to medical groups WHAT'S NEW: After analyzing the ambulatory enterprise market, Barclays analyst Eric Percher reported that only 12 of the 100 largest names on the list are potential targets for athenahealth. Additionally, those dozen groups are much smaller than the ones with which athenahealth made deals in 2014 and earlier this year, wrote Percher. Given his findings, the analyst expects athenahealth's revenue growth to decline going forward. In order to accelerate its growth, athenahealth needs large contract wins and those are unlikely to occur in the near-term, predicted the analyst, who downgraded the stock to Underweight from Equal Weight and lowered his price target on the name to $110 from $140. WHAT'S NOTABLE: JPMorgan analyst Michael Newshel assumed lead coverage of athenahealth today with an Overweight rating and $170 price target. In his note this morning on the space, Newshel said his firm's latest hospital CIO survey indicates there will be no slowdown in HIT investments despite the electronic health records adoption cycle maturing. PRICE ACTION: In morning trading, athenahealth fell 6.6% to $152.22.
|10:00 EDT||ATHN||On The Fly: Analyst Downgrade Summary|
Today's noteworthy downgrades include: Airgas (ARG) downgraded on valuation at KeyBanc... BHP Billiton (BHP) downgraded to Neutral from Buy at Clarksons Platou... Chesapeake (CHK) downgraded to Neutral from Buy at Sterne Agee CRT... ChipMOS (IMOS) downgraded to Equal Weight from Overweight at Morgan Stanley... Clovis (CLVS) downgraded to Neutral from Conviction Buy at Goldman... Cooper Companies (COO) downgraded to Market Perform from Outperform at Wells Fargo... Five Below (FIVE) downgraded to Neutral from Buy at Sterne Agee CRT... Grainger (GWW) downgraded to Underweight from Neutral at Atlantic Equities... Hess Corp. (HES) downgraded to Perform from Outperform at Oppenheimer... J Sainsbury (JSAIY) downgraded to Neutral from Buy at Citi... Kindred Biosciences (KIN) downgraded to Market Perform from Outperform at BMO Capital... Leju (LEJU) downgraded to Neutral from Buy at BofA/Merrill... Lombard Medical (EVAR) downgraded to Equal Weight from Overweight at Barclays... Osiris (OSIR) downgraded to Sell from Hold at Brean Capital... Polaris Industries (PII) downgraded on anemic ORV growth at Wedbush... SQM (SQM) downgraded to Hold from Buy at HSBC... Southwestern Energy (SWN) downgraded to Underperform from Neutral at Sterne Agee CRT... Starwood (HOT) downgraded to Outperform from Buy at CLSA... Urban Outfitters (URBN) downgraded to Hold from Buy at Cantor... WM Morrison (MRWSY) downgraded to Sell from Neutral at Citi... adidas (ADDDY) downgraded to Sector Perform from Outperform at RBC Capital... athenahealth (ATHN) downgraded to Underweight from Equal Weight at Barclays.
|06:26 EDT||ATHN||The Advisory Board initiated with an Overweight at JPMorgan|
Subscribe for More Information
|05:43 EDT||ATHN||athenahealth downgraded to Underweight from Equal Weight at Barclays|
Barclays analyst Eric Percher downgraded athenahealth to Underweight saying the company's physician and revenue growth will decline moving forward. An analysis of the ambulatory enterprise market indicates that potential athenahealth targets among the 100 largest health systems number only 12, Percher tells investors in a research note. Big enterprise wins are needed to drive growth but are "few and far between," the analyst contends. He cut his price target for athenahealth to $110 from $140. The provider of cloud-based services for medical groups and health systems closed yesterday up $1.77 to $162.98.